Publications
기타논문
Date: 2012
Journal: Biochip Journal Volume 6, Issue 3, 2012, Pages 280-292 , Doi: 10.1007/s13206-012-6311-4
2012 | The comparative analysis of in vivo and in vitro transcriptome data based on systems biology…
- Jo, Y.a, Oh, J.-H.b, Yoon, S.b, Bae, H.a, Hong, M.-C.a, Shin, M.-K.a, Kim, Y.S.a
Abstract
We investigated whether an in vitro cellbased system can represent toxicity of an in vivo organ using gene expression profiles. We performed an analysis of differentially expressed transcripts, pathway analysis, and Gene Ontology (GO) grouping with the toxicity-induced data following treatments with diclofenac, sulindac, itraconazole, and ketoconazole. The number of genes regulated in vitro and in vivo were much more than the randomly sampled number, but no significant correlation was observed between the in vitro and in vivo experiments. We performed a pathway analysis and GO grouping to expand the approach. In the pathway analysis, we narrowed down the hepatotoxic pathways to focus on toxicity. Then, the percentages of overlapping pathways increased. We found pathways associated with liver function in all experiments, such as the adipocyte signaling pathway, JAKSTAT signaling pathway, and peroxisome proliferatoractivated receptor (PPAR) signaling pathway. In the GO grouping analysis, the clusters obtained were primarily related to lipid metabolic and synthetic processes. The percentage of common GO terms between in vitro and in vivo experiments also increased. Therefore, we identified than an analysis performed at the systems biology level was more correlated for in vitro and in vivo systems. © 2012 The Korean BioChip Society and Springer-Verlag Berlin Heidelberg.
Author keywords
Bioinformatics; Comparative analysis; In vitro and in vivo; Systems biology; Transcriptome data
Indexed keywords
Engineering controlled terms: Bioinformatics; Cytology; Experiments; Gene expression; Toxicity
Adipocytes; Cell-based; Comparative analysis; Diclofenac; Gene expression profiles; Gene ontology; In-vitro; In-vivo; Itraconazole; Pathway analysis; Peroxisome proliferator-activated receptor; Signaling pathways; Synthetic process; Systems biology; Transcriptomes
Engineering main heading: Signaling
EMTREE drug terms: diclofenac; itraconazole; Janus kinase; ketoconazole; peroxisome proliferator activated receptor; STAT protein; sulindac; transcriptome
EMTREE medical terms: adipocyte; animal cell; article; comparative study; gene cluster; gene expression; gene expression regulation; in vitro study; in vivo study; lipid metabolism; liver function; liver toxicity; mouse; nonhuman; signal transduction; systems biology
Chemicals and CAS Registry Numbers: diclofenac, 15307-79-6, 15307-86-5; itraconazole, 84625-61-6; Janus kinase, 161384-16-3; ketoconazole, 65277-42-1; sulindac, 38194-50-2